RxDoctor Payments DataLook up a doctor →

George Pittman, MD

Family Medicine · Richmond, KYNPI 1033118864

Payments from drug & device makers

$12,129in general payments, 2019–2025

Across 828 payments — averaging $14.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Lilly USA, LLC$1K
  • AbbVie$995
  • GSK$870
  • Novo Nordisk$782
  • Vanda Pharmaceuticals Inc.$703
  • plus $6K from 41 others

What the payments were for

  • Food & beverage$12,098100%
  • Education$310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,129 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$135,003
Medicare patients
190
Services billed
6,739

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide167$209,551
EliquisApixaban135$150,607
OzempicSemaglutide101$123,923
Repatha SureclickEvolocumab133$98,939
Tresiba Flextouch U-200Insulin Degludec73$97,781
JardianceEmpagliflozin59$54,622
EntrestoSacubitril/Valsartan32$46,012
TrulicityDulaglutide31$44,729
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$43,048
FarxigaDapagliflozin Propanediol36$32,196
TrintellixVortioxetine Hydrobromide31$28,016
RexultiBrexpiprazole14$27,659
LinzessLinaclotide24$25,827
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog27$23,943
MyrbetriqMirabegron35$22,202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,250$254,281198 claims
PfizerEliquis$587$150,607135 claims
Novo NordiskOzempic, Xultophy 100-3.6$782$138,842113 claims
Boehringer IngelheimJardiance, Spiriva Respimat$262$72,79478 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$870$58,51982 claims
AstraZenecaFarxiga, Breztri Aerosphere, Nexium$470$54,50568 claims
NovartisEntresto$545$46,01232 claims
AbbVieLinzess, Namzaric, Synthroid$995$42,256127 claims
MerckBelsomra, Januvia$463$32,99859 claims
Arbor Pharmaceuticals, Inc.Edarbyclor, Edarbi$91$32,01962 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$263$28,01631 claims
Otsuka America Pharmaceutical, Inc.Rexulti$126$27,65914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Richmond

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →